Gift Opening
$200 Off MarketBeat All Access
Thanks for being one of our best subscribers! You are eligible for a limited-time discount.
  •  days
  •  Hours
  •  Minutes
  •  Seconds
Claim Your Discount
×
Free Trial

Trimble, CymaBay Therapy rise; Big Lots, Monday.com fall, Monday, 2/12/2024

NEW YORK (AP) — Stocks that traded heavily or had substantial price changes on Monday:

CymaBay Therapeutics Inc., up $6.52 to $32.21.

Gilead Sciences is buying the drug developer for about $4.3 billion.

V.F. Corp., up $2.14 to $17.44.

The maker of Vans, North Face and other brands reportedly faces pressure from activist investors.

Diamondback Energy Inc., up $14.24 to $165.98.

The oil and gas company wants to buy rival Endeavor Energy Resources.

Joby Aviation Inc., up 38 cents to $6.31.

The air taxi developer signed a deal with Dubai to launch services by early 2026.

Trimble Navigation Ltd., up $2.18 to $54.69.

The GPS manufacturer beat analysts' fourth-quarter earnings and revenue forecasts.

Big Lots Inc., down $1.50 to $3.86.

The discount retailer is reportedly seeking financing because of ongoing losses.

Beasley Broadcast Group Inc., up 1 cent to 84 cents.

The radio broadcaster beat Wall Street's fourth-quarter earnings forecasts.

Monday.com Ltd., down $23.91 to $212.01.

Investors were disappointed by the project management software developer's latest financial report.

Where should you invest $1,000 right now?

Before you make your next trade, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis.

Our team has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and none of the big name stocks were on the list.

They believe these five stocks are the five best companies for investors to buy now...

See The Five Stocks Here

20 Stocks to Sell Now Cover

MarketBeat has just released its list of 20 stocks that Wall Street analysts hate. These companies may appear to have good fundamentals, but top analysts smell something seriously rotten. Are any of these companies lurking around your portfolio? Find out by clicking the link below.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Broadcom’s Momentum Returns: Will It Reach New Highs?
Toyota’s Big Bet on Joby: Will Air Taxis Revolutionize Travel by 2025?
UnitedHealth Group: A Healthcare Giant with Strong Dividends

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines